Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Praga

Showing results (21-30 of 265) with videos related to

Pageof 27
Sort By:
Kidney International|September 24, 2019
Complement inhibitors are useful in secondary hemolytic uremic syndromesFernando Caravaca-Fontan, Manuel Praga
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 30, 2024
Microscopic hematuria in C3G and IC-MPGNFernando Caravaca-Fontán, Manuel Praga
Nephron|April 2, 2020
New Ways of Understanding Membranous NephropathyHernando Trujillo, Marina Alonso, Manuel Praga
Kidney International|May 21, 2026
The authors replyManuel Praga, Elena Goicoechea de Jorge
Kidney International Reports|October 8, 2021
Calcineurin Inhibitors in Membranous NephropathyClaudio Ponticelli, Manuel Praga, Gabriella Moroni
Kidney International|May 25, 2019
Secondary atypical hemolytic uremic syndromes in the era of complement blockadeManuel Praga, Santiago Rodríguez de Córdoba
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 24, 2026
Hematuria as a biomarker guiding treatment decisions in IgA nephropathy? YesEduardo Gutiérrez, Angel Sevillano, Manuel Praga
Contributions to Nephrology|February 8, 2012
Hepatitis C-induced renal disease in patients with AIDS: an emergent problemManuel Praga, Elena Gutiérrez Solís, Enrique Morales
Clinical Kidney Journal|June 25, 2024
Ten tips on immunosuppression in primary membranous nephropathyHernando Trujillo, Fernando Caravaca-Fontán, Manuel Praga
Advances in Kidney Disease and Health|September 14, 2025
Management of Acute Tubulointerstitial NephritisNamrata Krishnan, Fernando Caravaca-Fontán, Manuel Praga
Pageof 27

Showing results (21-30 of 265) with videos related to

Sort By:
Pageof 27
Kidney International|September 24, 2019
Complement inhibitors are useful in secondary hemolytic uremic syndromesFernando Caravaca-Fontan, Manuel Praga
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 30, 2024
Microscopic hematuria in C3G and IC-MPGNFernando Caravaca-Fontán, Manuel Praga
Nephron|April 2, 2020
New Ways of Understanding Membranous NephropathyHernando Trujillo, Marina Alonso, Manuel Praga
Kidney International|May 21, 2026
The authors replyManuel Praga, Elena Goicoechea de Jorge
Kidney International Reports|October 8, 2021
Calcineurin Inhibitors in Membranous NephropathyClaudio Ponticelli, Manuel Praga, Gabriella Moroni
Kidney International|May 25, 2019
Secondary atypical hemolytic uremic syndromes in the era of complement blockadeManuel Praga, Santiago Rodríguez de Córdoba
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 24, 2026
Hematuria as a biomarker guiding treatment decisions in IgA nephropathy? YesEduardo Gutiérrez, Angel Sevillano, Manuel Praga
Contributions to Nephrology|February 8, 2012
Hepatitis C-induced renal disease in patients with AIDS: an emergent problemManuel Praga, Elena Gutiérrez Solís, Enrique Morales
Clinical Kidney Journal|June 25, 2024
Ten tips on immunosuppression in primary membranous nephropathyHernando Trujillo, Fernando Caravaca-Fontán, Manuel Praga
Advances in Kidney Disease and Health|September 14, 2025
Management of Acute Tubulointerstitial NephritisNamrata Krishnan, Fernando Caravaca-Fontán, Manuel Praga
Pageof 27